Welcome to BioMarket Group!

Brazil Generics Market Forecast to 2012

Additional Information

Published Date Jan 11, 2011
Special Offer No
Pages 60
PDF Fact Sheet View Fact Sheet for the report Brazil Generics Market Forecast to 2012 in PDF format.
Published on Date No
Format PDF
Publisher RNCOS
Product Line No
Full Title No

Availability: In stock

$1,000.00

Quick Overview

Since the initial launch of policies, Brazil generic drugs market has been experiencing a stupendous growth. The country is the largest generics market in Latin America and is poised to...
Request free sample pages from Brazil Generics Market Forecast to 2012

Since the initial launch of policies, Brazil generic drugs market has been experiencing a stupendous growth. The country is the largest generics market in Latin America and is poised to become one of the fastest growing regions in coming years. This marvelous performance of the sector is accredited to various factors such as, patent expirations, liberal government policies, aging population, high investments etc. The Brazilian generics market is expected to witness a significant rise in revenue and consumption in future as good quality products, untapped space for growth, and the government support will back the industry. It is expected that the generics market will post a CAGR of nearly 19% during 2010 - 2012.

According to our latest report entitled "Brazil Generics Market Forecast to 2012", various segments of the Brazilian generic drugs sector has supported the overall market growth. Segments such as, diabetes, antithrombotics, erectile dysfunction, oral contraceptive, antiretroviral, and cardiovascular are the key growth areas of the industry. Of these, diabetes, antiretroviral, cardiovascular, and oral contraceptive holds a significant potential for future growth.

Our research report has found that there are various market trends that may impact the industry developments in near future. Growing presence of multinational players, rising registration of generics, and focus on generic active ingredients are some of the important trends. Emphasis on generic active ingredients is rising as the patents of older branded substances are about to expire and manufacturers are beginning to launch new versions. This trend holds prominent significance as it may further boost the generics and bring in investments.

The report provides a complete overview and rational analysis of the Brazilian generics market. It has covered key aspects of the industry and thoroughly examined market performance in recent years. A prudent analytical review of market drivers, disease profile, regulatory scenario, and industry restraints has also been provided that will help clients understand the key factors associated with the industry. Moreover, the competitive landscape section elaborates upon the recent developments of key players and their strengths and weaknesses.

1. Analyst View

2. Research Methodology

3. Market Overview

4. Market Drivers
4.1 Strong Investments
4.2 Government Initiatives
4.3 Patent Expiries
4.4 Aging Population
4.5 Increasing Prescription Rate

5. Industry Performance
5.1 Market Size & Growth
5.2 Pharma Market Vs Generics
5.3 By Therapeutics
5.3.1 Antiretroviral
5.3.2 Oral Contraceptives
5.3.3 Erectile Dysfunction
5.3.4 Anti-thrombotics
5.3.5 Cardiovascular Drugs
5.3.6 Anti-diabetics

6. Market Trends
6.1 Increasing Share of Foreign Firms
6.2 Rising Generic Registrations
6.3 Global Expansion
6.4 Focus on Generic Active Ingredients

7. Regulatory Environment

8. Industry Restraints & RNCOS Recommendation
8.1 Dependence on Imported Raw Materials
8.2 Over-reliance of Domestic Generic Firms on Domestic Market
8.3 Lack of Awareness & Slow Acceptance by Physicians
8.4 Prevalence of ’Similar Drugs’
8.5 Counterfeit Drugs

9. Key Players
9.1 EMS Sigma Pharma
9.2 Medley
9.3 Eurofarma Laboratories Ltd
9.4 Aché Pharmaceutical Laboratories S/A
9.5 Ranbaxy

Request free sample pages from Brazil Generics Market Forecast to 2012

Other selected research from the 'Brazil' category:


OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
Datamonitor’s OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) OTC Pharmaceuticals industry... Learn More


Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
Datamonitor’s Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report... Learn More

Other selected research from the 'Markets' category:


Japanese Generic Market Forecast to 2013
Generic drugs are produced and distributed without patent protection and marketed after the expiry date of patent or other rights. Usually, generic drugs are as effective as their master drugs... Learn More


Global Generics Guide: Part 2 - Benchmarking country markets and strategic issues
The generics market is undergoing significant change, with intense merger and acquisition activity, a raft of upcoming patent expiries and new legislation being enacted to promote generic prescription in the major markets. In addition, key issues, such as authorized generics, the first biosimilars approvals and increasing competition within the market are also affecting growth dynamics Learn More